生技
生物科技板塊聚焦以生命科學為基礎的研發與商業化，涵蓋藥物研發、基因與細胞治療、診斷試劑、合成生物與精準醫療等核心賽道。該板塊總市值為 918.48 billion HKD，24h 漲跌幅 -0.20%，14 檔中，6 檔上漲 (42.86%)，8 檔下跌 (57.14%)。領漲個股為 金斯瑞生物科技 (01548)，24h 漲幅為 +4.47%。在溫和盤整中，由領頭股帶動的韌性顯示這是暫停，而非趨勢反轉。以即將到來的催化事件為動能交易的重點；在回調時逢低布局現金充裕的創新型公司，優先考量已驗證的研發管線與風險控管，而非投機性標的。
名稱 | 最新價 | 漲跌幅 | 最新價 / 漲跌幅 | 走勢圖 | 價格區間 | 操作 |
|---|---|---|---|---|---|---|
 藥明生物02269 | HK$38.66$159.49 | -1.12%-$1.81 | HK$38.66 -1.12% | $158.75$163.62 | ||
 藥明康德02359 | HK$157.0$647.7 | -0.25%-$1.6 | HK$157.0 -0.25% | $645.2$659.2 | ||
 百濟神州06160 | HK$199.7$823.8 | +0.25%+$2.0 | HK$199.7 +0.25% | $816.0$826.7 | ||
 金斯瑞生物科技01548 | HK$16.82$69.39 | +4.47%+$2.97 | HK$16.82 +4.47% | $66.29$69.39 | ||
 康方生物09926 | HK$98.60$406.78 | -0.90%-$3.71 | HK$98.60 -0.90% | $401.63$411.32 | ||
 科倫博泰生物－Ｂ06990 | HK$513.5$2,118.5 | -0.09%-$2.0 | HK$513.5 -0.09% | $2,091.6$2,145.3 | ||
 榮昌生物09995 | HK$85.65$353.36 | +2.94%+$10.10 | HK$85.65 +2.94% | $343.25$355.83 | ||
 康諾亞－Ｂ02162 | HK$82.30$339.53 | -0.60%-$2.06 | HK$82.30 -0.60% | $335.62$343.66 | ||
 藥明合聯02268 | HK$54.35$224.22 | -2.16%-$4.95 | HK$54.35 -2.16% | $222.37$232.27 | ||
 ZAI LAB09688 | HK$14.87$61.34 | -3.31%-$2.10 | HK$14.87 -3.31% | $60.68$63.65 | ||
 泰格醫藥03347 | HK$37.84$156.11 | +1.72%+$2.64 | HK$37.84 +1.72% | $152.48$158.01 | ||
 諾誠健華09969 | HK$13.91$57.38 | +0.79%+$0.45 | HK$13.91 +0.79% | $56.68$58.00 | ||
 復宏漢霖02696 | HK$56.00$231.03 | -0.17%-$0.41 | HK$56.00 -0.17% | $228.56$233.30 | ||
 君實生物－Ｂ01877 | HK$18.90$77.97 | +2.77%+$2.10 | HK$18.90 +2.77% | $75.87$78.09 |